Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

BUY
$2.15 - $3.49 $2,322 - $3,769
1,080 Added 5.93%
19,280 $44,000
Q1 2023

May 03, 2023

BUY
$1.99 - $2.68 $36,218 - $48,776
18,200 New
18,200 $44,000
Q1 2022

May 12, 2022

SELL
$1.95 - $3.89 $75,465 - $150,543
-38,700 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$3.81 - $6.16 $147,447 - $238,392
38,700 New
38,700 $152,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $302M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.